Document is current

Documents that mention this clinical trial

Drug treatments for covid-19: living systematic review and network meta-analysis
https://doi.org/10.1136/bmj.m2980

Producing and using timely comparative evidence on drugs: lessons from clinical trials for covid-19
https://doi.org/10.1136/bmj.m3869

Retrospective analysis of high flow nasal therapy in COVID-19-related moderate-to-severe hypoxaemic respiratory failure
https://doi.org/10.1136/bmjresp-2020-000650

Remdesivir for severe covid-19: a clinical practice guideline
https://doi.org/10.1136/bmj.m2924

Documents that mention this clinical trial

Drug treatments for covid-19: living systematic review and network meta-analysis
https://doi.org/10.1136/bmj.m2980

Producing and using timely comparative evidence on drugs: lessons from clinical trials for covid-19
https://doi.org/10.1136/bmj.m3869

Retrospective analysis of high flow nasal therapy in COVID-19-related moderate-to-severe hypoxaemic respiratory failure
https://doi.org/10.1136/bmjresp-2020-000650

Remdesivir for severe covid-19: a clinical practice guideline
https://doi.org/10.1136/bmj.m2924

Documents that mention this clinical trial

The Society for Immunotherapy of Cancer perspective on regulation of interleukin-6 signaling in COVID-19-related systemic inflammatory response
https://doi.org/10.1136/jitc-2020-000930

Retrospective analysis of high flow nasal therapy in COVID-19-related moderate-to-severe hypoxaemic respiratory failure
https://doi.org/10.1136/bmjresp-2020-000650

Adaptations to the British Society of Gastroenterology guidelines on the management of acute severe UC in the context of the COVID-19 pandemic: a RAND appropriateness panel
https://doi.org/10.1136/gutjnl-2020-321927